FI864756A0 - Plasmidi humaani mangaanisuperoksididismutaasin ilmentämiseksi bakteereissa sekä menetelmä entsymaattisesti aktiivisen humaani mangaanisuperoksididismutaasin tuottamiseksi ja talteenottamiseksi - Google Patents

Plasmidi humaani mangaanisuperoksididismutaasin ilmentämiseksi bakteereissa sekä menetelmä entsymaattisesti aktiivisen humaani mangaanisuperoksididismutaasin tuottamiseksi ja talteenottamiseksi

Info

Publication number
FI864756A0
FI864756A0 FI864756A FI864756A FI864756A0 FI 864756 A0 FI864756 A0 FI 864756A0 FI 864756 A FI864756 A FI 864756A FI 864756 A FI864756 A FI 864756A FI 864756 A0 FI864756 A0 FI 864756A0
Authority
FI
Finland
Prior art keywords
superoxide dismutase
manganese superoxide
human manganese
plasmid
bacteria
Prior art date
Application number
FI864756A
Other languages
English (en)
Swedish (sv)
Other versions
FI90353B (fi
FI90353C (fi
FI864756A (fi
Inventor
Jacob R Hartman
Yaffa Beck
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of FI864756A0 publication Critical patent/FI864756A0/fi
Publication of FI864756A publication Critical patent/FI864756A/fi
Publication of FI90353B publication Critical patent/FI90353B/fi
Application granted granted Critical
Publication of FI90353C publication Critical patent/FI90353C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI864756A 1985-11-22 1986-11-21 Plasmidi humaani mangaanisuperoksididismutaasin ilmentämiseksi bakteereissa sekä menetelmä entsymaattisesti aktiivisen humaani mangaanisuperoksididismutaasin tuottamiseksi ja talteenottamiseksi FI90353C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80109085A 1985-11-22 1985-11-22
US80109085 1985-11-22
US90705186A 1986-09-12 1986-09-12
US90705186 1986-09-12

Publications (4)

Publication Number Publication Date
FI864756A0 true FI864756A0 (fi) 1986-11-21
FI864756A FI864756A (fi) 1987-05-23
FI90353B FI90353B (fi) 1993-10-15
FI90353C FI90353C (fi) 1994-01-25

Family

ID=27122291

Family Applications (1)

Application Number Title Priority Date Filing Date
FI864756A FI90353C (fi) 1985-11-22 1986-11-21 Plasmidi humaani mangaanisuperoksididismutaasin ilmentämiseksi bakteereissa sekä menetelmä entsymaattisesti aktiivisen humaani mangaanisuperoksididismutaasin tuottamiseksi ja talteenottamiseksi

Country Status (21)

Country Link
JP (2) JP2609449B2 (fi)
AT (1) AT400443B (fi)
AU (1) AU607897B2 (fi)
BE (1) BE905796A (fi)
CA (1) CA1341362C (fi)
CH (1) CH676990A5 (fi)
DE (1) DE3639725C2 (fi)
DK (1) DK534686A (fi)
ES (1) ES2003518A6 (fi)
FI (1) FI90353C (fi)
FR (1) FR2590591B1 (fi)
GB (1) GB2183658B (fi)
GR (1) GR862713B (fi)
HK (1) HK75195A (fi)
IE (1) IE59498B1 (fi)
IL (2) IL106449A (fi)
IT (1) IT1205418B (fi)
LU (1) LU86676A1 (fi)
NL (1) NL8602960A (fi)
PT (1) PT83792B (fi)
SE (1) SE8604884L (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610520B1 (en) 1985-11-22 2003-08-26 Bio-Technology General Corp. Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
JPS62215532A (ja) * 1986-03-18 1987-09-22 Ube Ind Ltd 抗炎症剤
JPH0643341B2 (ja) * 1986-03-27 1994-06-08 宇部興産株式会社 臓器機能改善剤
JPH0643340B2 (ja) * 1986-09-03 1994-06-08 宇部興産株式会社 虚血性心疾患治療薬
JPS6377822A (ja) * 1986-09-18 1988-04-08 Ube Ind Ltd 臓器機能改善剤
US6326003B1 (en) 1986-10-14 2001-12-04 Chiron Corporation Manganese superoxide dismutase cloning and expression in microorganisms
DE3854872D1 (de) * 1987-03-14 1996-02-22 Boehringer Ingelheim Int Humane Mangan-Superoxiddismutase (hMn-SOD)
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
ATE130196T1 (de) * 1987-03-27 1995-12-15 Bio Technology General Corp Menschliches mangansuperoxiddismutase und behandlungsverfahren.
JPH01233228A (ja) * 1988-03-11 1989-09-19 Toyo Jozo Co Ltd 悪性腫瘍細胞転移防止剤
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
DE4038563A1 (de) * 1990-12-04 1992-06-11 Gruenenthal Gmbh Verwendung von superoxiddismutasen zur prophylaxe und/oder behandlung von organversagen bei risikopatienten mit polytrauma
ATE209928T1 (de) * 1992-09-09 2001-12-15 Bio Technology General Corp Verwendung von mangan-superoxiddismutase (mn-sod) zur herstellung von arzneimitteln zur behandlung von erkrankungen in niedriger dosierung
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56102787A (en) * 1980-01-18 1981-08-17 Mamoru Sugiura Preparation of human placenta superoxide dismutase
BG49718A3 (en) * 1983-07-15 1992-01-15 Bio Technology General Corp Method for preparing of polypeptid with superoxiddismutasne activitty
EP0138111B1 (en) * 1983-10-03 1991-11-21 Chiron Corporation Superoxide dismutase cloning and expression in microorganisms

Also Published As

Publication number Publication date
IL106449A0 (en) 1993-11-15
JP2609449B2 (ja) 1997-05-14
CA1341362C (en) 2002-05-28
ATA308986A (de) 1995-05-15
PT83792B (pt) 1989-01-17
IE59498B1 (en) 1994-03-09
IT1205418B (it) 1989-03-15
SE8604884L (sv) 1987-05-23
IL80702A0 (en) 1987-02-27
BE905796A (fr) 1987-03-16
HK75195A (en) 1995-05-26
JPH08289792A (ja) 1996-11-05
SE8604884D0 (sv) 1986-11-14
GR862713B (en) 1987-03-24
FI90353B (fi) 1993-10-15
FR2590591A1 (fr) 1987-05-29
LU86676A1 (fr) 1987-05-04
DK534686D0 (da) 1986-11-07
FI90353C (fi) 1994-01-25
JP2967557B2 (ja) 1999-10-25
GB8627294D0 (en) 1986-12-17
AT400443B (de) 1995-12-27
IL106449A (en) 1997-02-18
FR2590591B1 (fr) 1989-12-01
IT8667865A0 (it) 1986-11-21
GB2183658B (en) 1990-04-25
AU6497586A (en) 1987-05-28
ES2003518A6 (es) 1988-11-01
NL8602960A (nl) 1987-06-16
FI864756A (fi) 1987-05-23
AU607897B2 (en) 1991-03-21
DE3639725A1 (de) 1987-07-23
PT83792A (en) 1986-12-01
DK534686A (da) 1987-05-23
GB2183658A (en) 1987-06-10
IE862851L (en) 1987-05-22
CH676990A5 (fi) 1991-03-28
JPS62289187A (ja) 1987-12-16
DE3639725C2 (de) 1998-02-19

Similar Documents

Publication Publication Date Title
FI864756A0 (fi) Plasmidi humaani mangaanisuperoksididismutaasin ilmentämiseksi bakteereissa sekä menetelmä entsymaattisesti aktiivisen humaani mangaanisuperoksididismutaasin tuottamiseksi ja talteenottamiseksi
CS938286A2 (en) Fungicide and method of active substances production
HUT42479A (en) Process for production of derivatives of quinasoline and medical preparatives containing thereof as active substance
ATE99928T1 (de) Ester des retinols und/oder der retinsaeure enthaltende aerosol-inhalate.
PT81958A (en) A pack of plant source material and method of production
DK155587A (da) Elektrooptisk induceret optisk boelgeleder og aktiv anordning omfattende en saadan boelgeleder
NO175716C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, totale og partielle hyaluronsyre-estere
PT82591A (en) Ascorbic acid derivatives production and use thereof
ES554218A0 (es) Un metodo de produccion de actividad de isopenicilina n sintetasa en una celula huesped
HUT43580A (en) Process for production of derivatives of carbonic acid and medical compounds containing thereof as active substance
IT1189877B (it) Liposomi fusogenici e metodo per prepararli
FR2620450B1 (fr) Nouveaux sels de composes organogermaniques et medicaments les contenant
PL263008A1 (en) Nematocides and insecticides and a method of active matter production
FR2565107B1 (fr) Nouveau medicament a base de charbon actif et son procede de preparation
GB2169510B (en) Method of treatment of viral diseases in plants utilizing ribavirin
HUT43844A (en) Process for production of derivatives of benzamid and medical preparatives containing thereof
HUT44789A (en) Process for production of bicycloalcane derivatives and insecticides and acarycides containing them as active substance
KR870700351A (ko) 기관지경련성 기도질병의 치료방법 및 치료용 조성물
FR2591598B1 (fr) Nouveaux derives d'acide ceph-3-em-4-carboxylique, leur preparation et medicaments les contenant
HUT41016A (en) Process for production of n-phenil-4-phenil-1-piperazincarboxamidines and medical preparatives containing thereof as active substances
HUT40104A (en) Process for production of 3-substituated-1-h-imidasoles and medical preparatives containing thereof as active subtance
FR2554445B1 (fr) Acides 4-(3-acylamino-2-oxo-1-azetidinyl)-4-oxo-2-butenoiques utiles notamment comme antibacteriens et medicaments les contenant
AU575958B2 (en) Preservation of proteins with ascorbic acid and gallic acid salts
AU4124189A (en) Novel pyridyl aminoethanols with animal growth promotion activity and a high degree of safety
JPS54160398A (en) Quinolopyranee44onee22carboxylic acid ester derivative and antiiallergic asthma therapeutic medicine

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: BIO-TECHNOLOGY GENERAL CORP.